Annual long term liabilities:
$35.30B+$3.89B(+12.37%)Summary
- As of today (May 29, 2025), AZN annual total long term liabilities is $35.30 billion, with the most recent change of +$3.89 billion (+12.37%) on December 31, 2024.
- During the last 3 years, AZN annual long term liabilities has fallen by -$8.18 billion (-18.82%).
- AZN annual long term liabilities is now -18.82% below its all-time high of $43.48 billion, reached on December 31, 2021.
Performance
AZN Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$35.99B(NaN%)Summary
- As of today (May 29, 2025), AZN quarterly total long term liabilities is $35.99 billion
- Over the past year, AZN quarterly long term liabilities has increased by +$102.00 million (+0.28%).
- AZN quarterly long term liabilities is now -17.56% below its all-time high of $43.66 billion, reached on September 30, 2021.
Performance
AZN quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AZN Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +12.4% | +0.3% |
3 y3 years | -18.8% | -12.6% |
5 y5 years | +23.1% | +28.8% |
AZN Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -18.8% | +12.4% | -12.6% | +18.9% |
5 y | 5-year | -18.8% | +23.1% | -17.6% | +28.8% |
alltime | all time | -18.8% | +2135.9% | -17.6% | +2183.8% |
AZN Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $35.99B(-5.8%) |
Dec 2024 | $35.30B(+12.4%) | - |
Sep 2024 | - | $38.19B(+5.6%) |
Jun 2024 | - | $36.18B(+0.8%) |
Mar 2024 | - | $35.89B(+18.5%) |
Dec 2023 | $31.41B(-5.2%) | - |
Sep 2023 | - | $30.28B(-7.6%) |
Jun 2023 | - | $32.75B(-9.1%) |
Mar 2023 | - | $36.02B(+8.7%) |
Dec 2022 | $33.13B(-23.8%) | $33.13B(-3.1%) |
Sep 2022 | - | $34.18B(-11.9%) |
Jun 2022 | - | $38.81B(-5.7%) |
Mar 2022 | - | $41.17B(-5.3%) |
Dec 2021 | $43.48B(+41.2%) | $43.48B(-0.4%) |
Sep 2021 | - | $43.66B(+22.2%) |
Jun 2021 | - | $35.73B(+23.3%) |
Mar 2021 | - | $28.97B(-5.9%) |
Dec 2020 | $30.78B(+7.4%) | $30.78B(-2.4%) |
Sep 2020 | - | $31.55B(+12.3%) |
Jun 2020 | - | $28.09B(+0.5%) |
Mar 2020 | - | $27.95B(-2.5%) |
Dec 2019 | $28.66B(-5.4%) | $28.66B(-5.9%) |
Sep 2019 | - | $30.46B(-1.0%) |
Jun 2019 | - | $30.78B(+0.0%) |
Mar 2019 | - | $30.77B(+1.5%) |
Dec 2018 | $30.32B(-0.0%) | $30.32B(-7.2%) |
Sep 2018 | - | $32.66B(+9.3%) |
Jun 2018 | - | $29.87B(-2.2%) |
Mar 2018 | - | $30.54B(+0.7%) |
Dec 2017 | $30.33B(-0.9%) | $30.33B(-12.5%) |
Sep 2017 | - | $34.68B(+1.8%) |
Jun 2017 | - | $34.05B(+10.7%) |
Mar 2017 | - | $30.75B(+0.5%) |
Dec 2016 | $30.60B(+14.7%) | $30.60B(-7.1%) |
Sep 2016 | - | $32.93B(-5.1%) |
Jun 2016 | - | $34.69B(+9.3%) |
Mar 2016 | - | $31.75B(+19.0%) |
Dec 2015 | $26.68B(+23.4%) | $26.68B(+28.8%) |
Sep 2015 | - | $20.71B(-0.0%) |
Jun 2015 | - | $20.72B(-1.3%) |
Mar 2015 | - | $20.99B(-2.9%) |
Dec 2014 | $21.62B(+30.3%) | $21.62B(+8.8%) |
Sep 2014 | - | $19.87B(-1.4%) |
Jun 2014 | - | $20.16B(-1.2%) |
Mar 2014 | - | $20.40B(+22.9%) |
Dec 2013 | $16.59B(+5.8%) | $16.59B(+3.7%) |
Sep 2013 | - | $16.00B(+4.0%) |
Jun 2013 | - | $15.38B(-3.8%) |
Mar 2013 | - | $15.98B(+1.9%) |
Dec 2012 | $15.69B(+15.2%) | $15.69B(-2.3%) |
Sep 2012 | - | $16.06B(+11.9%) |
Jun 2012 | - | $14.35B(+8.4%) |
Mar 2012 | - | $13.24B(-2.7%) |
Dec 2011 | $13.61B(-14.6%) | $13.61B(-1.1%) |
Sep 2011 | - | $13.77B(-12.6%) |
Jun 2011 | - | $15.75B(-1.4%) |
Mar 2011 | - | $15.97B(+0.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | $15.93B(-3.2%) | $15.93B(-7.5%) |
Sep 2010 | - | $17.23B(+7.1%) |
Jun 2010 | - | $16.08B(-0.7%) |
Mar 2010 | - | $16.19B(-1.6%) |
Dec 2009 | $16.46B(-5.8%) | $16.46B(-4.5%) |
Sep 2009 | - | $17.23B(+0.7%) |
Jun 2009 | - | $17.11B(+1.1%) |
Mar 2009 | - | $16.94B(-3.1%) |
Dec 2008 | $17.48B(-2.1%) | $17.48B(-0.2%) |
Sep 2008 | - | $17.52B(-3.3%) |
Jun 2008 | - | $18.12B(+1.2%) |
Mar 2008 | - | $17.91B(+0.3%) |
Dec 2007 | $17.86B(+252.2%) | $17.86B(+13.9%) |
Sep 2007 | - | $15.68B(+103.6%) |
Jun 2007 | - | $7.70B(+48.2%) |
Mar 2007 | - | $5.19B(+2.5%) |
Dec 2006 | $5.07B(+17.6%) | $5.07B(-3.5%) |
Sep 2006 | - | $5.25B(+4.1%) |
Jun 2006 | - | $5.04B(-0.5%) |
Mar 2006 | - | $5.07B(+17.6%) |
Dec 2005 | $4.31B(-5.6%) | $4.31B(-2.4%) |
Sep 2005 | - | $4.42B(-2.2%) |
Jun 2005 | - | $4.52B(+4.8%) |
Mar 2005 | - | $4.31B(-5.6%) |
Dec 2004 | $4.57B(+74.3%) | $4.57B(+63.6%) |
Sep 2004 | - | $2.79B(-39.1%) |
Jun 2004 | - | $4.58B(+26.5%) |
Mar 2004 | - | $3.62B(+38.2%) |
Dec 2003 | $2.62B(+22.8%) | $2.62B(+9.5%) |
Sep 2003 | - | $2.39B(+4.4%) |
Jun 2003 | - | $2.29B(+4.3%) |
Mar 2003 | - | $2.20B(+3.0%) |
Dec 2002 | $2.13B(-10.6%) | $2.13B(+2.5%) |
Sep 2002 | - | $2.08B(+1.6%) |
Jun 2002 | - | $2.05B(-9.5%) |
Mar 2002 | - | $2.26B(-5.1%) |
Dec 2001 | $2.39B(+19.5%) | $2.39B(-11.9%) |
Sep 2001 | - | $2.71B(+4.0%) |
Jun 2001 | - | $2.61B(+1.3%) |
Mar 2001 | - | $2.57B(+28.8%) |
Dec 2000 | $2.00B(-18.7%) | $2.00B(-16.1%) |
Sep 2000 | - | $2.38B(-3.9%) |
Jun 2000 | - | $2.48B(+24.4%) |
Mar 2000 | - | $1.99B(-18.8%) |
Dec 1999 | $2.46B(+33.0%) | $2.46B(+3.3%) |
Sep 1999 | - | $2.38B(-4.3%) |
Jun 1999 | - | $2.48B(+34.5%) |
Dec 1998 | $1.85B(+16.9%) | $1.85B(+17.1%) |
Jun 1998 | - | $1.58B(-0.2%) |
Dec 1997 | $1.58B(-7.1%) | $1.58B(-7.1%) |
Dec 1996 | $1.70B(-0.4%) | $1.70B(-0.4%) |
Dec 1995 | $1.71B(+4.7%) | $1.71B(+4.4%) |
Jun 1995 | - | $1.63B(+0.3%) |
Dec 1994 | $1.63B(+1.2%) | $1.63B(+1.2%) |
Dec 1993 | $1.61B(-21.5%) | $1.61B |
Dec 1992 | $2.05B(-44.8%) | - |
Dec 1991 | $3.71B(-2.3%) | - |
Dec 1990 | $3.80B | - |
FAQ
- What is AstraZeneca annual total long term liabilities?
- What is the all time high annual long term liabilities for AstraZeneca?
- What is AstraZeneca annual long term liabilities year-on-year change?
- What is AstraZeneca quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for AstraZeneca?
- What is AstraZeneca quarterly long term liabilities year-on-year change?
What is AstraZeneca annual total long term liabilities?
The current annual long term liabilities of AZN is $35.30B
What is the all time high annual long term liabilities for AstraZeneca?
AstraZeneca all-time high annual total long term liabilities is $43.48B
What is AstraZeneca annual long term liabilities year-on-year change?
Over the past year, AZN annual total long term liabilities has changed by +$3.89B (+12.37%)
What is AstraZeneca quarterly total long term liabilities?
The current quarterly long term liabilities of AZN is $35.99B
What is the all time high quarterly long term liabilities for AstraZeneca?
AstraZeneca all-time high quarterly total long term liabilities is $43.66B
What is AstraZeneca quarterly long term liabilities year-on-year change?
Over the past year, AZN quarterly total long term liabilities has changed by +$102.00M (+0.28%)